Maryland HB393 mandates coverage for scalp cooling systems used to prevent hair loss during chemotherapy for cancer patients.
Maryland HB393 requires insurers, nonprofit health service plans, health maintenance organizations, and managed care organizations that cover chemotherapy for cancer to also cover scalp cooling systems. These systems cool the scalp to reduce hair loss during chemotherapy. The law applies to policies issued, delivered, or renewed in Maryland on or after January 1, 2027.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.